Sildenafil Reduces Insulin-Resistance in Human Endothelial Cells
Author Information
Author(s): Mammi Caterina, Pastore Donatella, Lombardo Marco F., Ferrelli Francesca, Caprio Massimiliano, Consoli Claudia, Tesauro Manfredi, Gatta Lucia, Fini Massimo, Federici Massimo, Sbraccia Paolo, Donadel Giulia, Bellia Alfonso, Rosano Giuseppe M., Fabbri Andrea, Lauro Davide
Primary Institution: Centre for Clinical and Basic Research, IRCCS San Raffaele Pisana, Rome, Italy
Hypothesis
Can sildenafil improve nitric oxide production and insulin signaling in endothelial cells under insulin resistance conditions?
Conclusion
Sildenafil may enhance nitric oxide production and improve insulin signaling in endothelial cells, suggesting its potential therapeutic use for vascular function in diabetic patients.
Supporting Evidence
- Sildenafil treatment significantly increased nitric oxide production in endothelial cells.
- Insulin treatment alone did not induce nitric oxide production in insulin-resistant conditions.
- Sildenafil improved eNOS phosphorylation, which is crucial for nitric oxide production.
- Chronic sildenafil treatment enhanced nitric oxide production in both basal and insulin-resistant conditions.
Takeaway
Sildenafil, a drug often used for erectile dysfunction, can help blood vessels work better in people with diabetes by increasing a substance called nitric oxide.
Methodology
Human umbilical vein endothelial cells (HUVECs) were treated with insulin and glucose, with or without sildenafil, and various assays were performed to measure nitric oxide production and protein expression.
Limitations
The study was conducted in vitro, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website